What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His scientific interests lie mostly in Immunology, Internal medicine, Transplantation, Chronic lymphocytic leukemia and Leukemia.
His study in Immunology concentrates on Antigen, Immune system, CD28, T cell and Lymphoma.
His Antigen study combines topics in areas such as Immunotherapy and Antigen-presenting cell.
John G. Gribben interconnects Gastroenterology, Surgery and Oncology in the investigation of issues within Internal medicine.
The Transplantation study combines topics in areas such as Stem cell and Bone marrow.
His research in Chronic lymphocytic leukemia intersects with topics in Hematopoietic stem cell transplantation, Disease, Clinical trial and Antibody.
His most cited work include:
- Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation (906 citations)
- ZAP-70 Compared with Immunoglobulin Heavy-Chain Gene Mutation Status as a Predictor of Disease Progression in Chronic Lymphocytic Leukemia (836 citations)
- Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. (654 citations)
What are the main themes of his work throughout his whole career to date?
John G. Gribben mainly focuses on Internal medicine, Immunology, Chronic lymphocytic leukemia, Cancer research and Oncology.
John G. Gribben has researched Internal medicine in several fields, including Gastroenterology and Surgery.
His Immunology research focuses on Cytotoxic T cell and how it connects with CD8.
His work deals with themes such as Antibody and Fludarabine, which intersect with Chronic lymphocytic leukemia.
He combines subjects such as Cancer, Signal transduction, Apoptosis and Diffuse large B-cell lymphoma with his study of Cancer research.
His Oncology study incorporates themes from Relapsed refractory, Clinical trial, Disease and Chemotherapy.
He most often published in these fields:
- Internal medicine (39.76%)
- Immunology (36.88%)
- Chronic lymphocytic leukemia (26.51%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (39.76%)
- Cancer research (25.72%)
- Oncology (24.80%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Cancer research, Oncology, Chronic lymphocytic leukemia and Ibrutinib.
The concepts of his Cancer research study are interwoven with issues in Cytokine, Leukemia, Flow cytometry and Diffuse large B-cell lymphoma.
His Oncology study integrates concerns from other disciplines, such as Hematopoietic stem cell transplantation and Transplantation.
His study in Transplantation is interdisciplinary in nature, drawing from both Human leukocyte antigen, Multiple myeloma and Clinical trial.
His Chronic lymphocytic leukemia study is concerned with the field of Immunology as a whole.
He is interested in Immune system, which is a field of Immunology.
Between 2016 and 2021, his most popular works were:
- Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma. (378 citations)
- Chronic lymphocytic leukaemia. (192 citations)
- Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial (189 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
John G. Gribben focuses on Internal medicine, Cancer research, Oncology, Disease and Ibrutinib.
His Cancer research research includes elements of Tumor progression, Leukemia, Malignancy and Bone marrow.
His Oncology research is multidisciplinary, relying on both Chlorambucil, Hematopoietic stem cell transplantation, Diffuse large B-cell lymphoma, Pathology and Histocompatibility Testing.
The various areas that John G. Gribben examines in his Disease study include Cancer, Lymphocytic leukaemia, Adverse effect, Immune system and Autologous stem-cell transplantation.
His Chronic lymphocytic leukemia study is concerned with the larger field of Immunology.
His studies deal with areas such as Transcriptome and Somatic evolution in cancer as well as Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
